Overview of Albatel

Quick Facts

Property	Description
Active ingredient	Albendazole
Form	Tablet or Oral Suspension
Pharmacological class	Anthelmintic, Benzimidazole derivative
Common use	Systemic parasitic worm infections (Helminthiasis)
Origin	Synthetic compound

What Type of Medicine is Albatel and What is its Purpose?

Albatel is classified as a prescription-only anthelmintic agent, meaning it is specifically designed to kill or expel parasitic worms from the body. The active ingredient, Albendazole (INN), belongs to the Benzimidazole chemical class, a family of compounds used for their efficacy against a wide variety of parasites. Its primary function is to systematically address the burden of parasitic worm infections (helminthiasis), such as confirmed intestinal worm infestation. Benzimidazoles are used for most nematode infections.

Albendazole: Core Composition and Forms

This medication is a synthetic, single-active ingredient product formulated for the oral route of administration. The Albendazole is combined with inert excipients to create the final, stable dosage form(s), which are typically presented as a tablet (which may be chewable) or a liquid oral suspension. The choice of a liquid suspension is often utilized for pediatric patients or those who have difficulty swallowing, representing a key patient-group-specific feature. Albendazole is a tubulin modulator and a microtubule-destabilizing agent.

How Albendazole Works to Eliminate Parasites

The general principle of action relies on the drug's ability to selectively interfere with the parasite’s cell biology. Albendazole works by disrupting the parasite's microscopic support structures (microtubules) and inhibiting their uptake of glucose. This combined effect starves the parasites and causes structural failure. This action carries larvicidal and ovicidal properties, ensuring the medication not only affects the adult worms but also their larvae and eggs, effectively stopping the entire infection lifecycle. This comprehensive effect contributes to achieving complete parasite clearance.

Regulatory References

Albendazole - StatPearls - NCBI Bookshelf - NIH

What side effects are possible with Albatel?

Possible side effects and safety information

Albatel (Albendazole) has an officially documented safety profile, with potential adverse effects classified by frequency and grouped according to the physiological system they affect, based on government regulatory standards.

Adverse Reaction Categories

Side effects are categorized based on regulatory documents:

Common Reactions (occurring in 1% to 10% of users): Officially listed effects include headache, abdominal pain, nausea, vomiting, and mild-to-moderate elevation of liver enzymes (transaminases).
Uncommon Reactions (occurring in 0.1% to 1% of users): These may include dizziness, vertigo, and reversible alopecia (hair thinning or loss).
Rare Reactions (occurring in less than 0.01% of users): The official safety profile notes the potential for severe, clinically significant adverse reactions. These focus on the Blood and Lymphatic System Disorders (e.g., aplastic anemia, pancytopenia, agranulocytosis) and severe Hepatobiliary Disorders (e.g., acute liver failure, hepatitis). Severe dermatological reactions, such as Stevens-Johnson Syndrome, are also documented as rare events.

Safety Considerations and Limitations

The official labeling defines specific safety limitations and monitoring requirements:

Mandatory Monitoring: Government regulatory documents require the periodic monitoring of blood cell counts and liver function tests throughout the course of therapy. Treatment must be discontinued if clinically significant decreases in blood counts or elevations in liver enzymes occur.
Reproductive Safety: Due to documented risk of embryo-fetal toxicity, use is restricted or contraindicated during pregnancy. Women of childbearing potential are officially advised to use effective contraception during and for a period following treatment.
Time-Related Patterns: The mild elevation of liver enzymes often occurs at the start of treatment, and any associated hair loss is classified as reversible upon cessation of the medication.

Overdose and Emergency Response

Overdose and when to seek help

The information below summarizes the official overdose findings and required emergency actions as documented in government regulatory sources.

Domain	Regulatory Documentation Statement
Documented overdose presentations	Manifestations are an exaggeration of symptoms associated with excessive beta-adrenergic stimulation, including tachycardia, tremor, nervousness, headache, and palpitations (pounding heartbeat).
Physiological systems affected (as stated in label)	Cardiovascular system (e.g., arrhythmias, cardiac arrest, hypertension/hypotension), Neurological system (e.g., seizures), and Metabolic system (e.g., hypokalaemia, lactic acidosis).
Dose-related or exposure-related factors (if applicable)	Excessive use of inhaled sympathomimetic drugs is associated with severe outcomes. Large doses are reported to aggravate pre-existing diabetes mellitus and ketoacidosis in certain patients.
Population-specific overdose notes (if applicable)	Caution is noted for patients with convulsive disorders or cardiovascular disorders due to increased susceptibility to effects.

Severity classification (as defined in official documents): Overdose effects are defined as severe, potentially leading to fatalities or cardiac arrest. Paradoxical bronchospasm is described as a life-threatening event.

When immediate medical help is required (label-derived phrasing only):

Seek emergency medical attention immediately, as an overdose can be fatal. This includes contacting emergency services or a Poison Control center.
Seek medical attention immediately if treatment becomes less effective or the patient requires more doses than usual.
Discontinuation of the medication is required immediately if paradoxical bronchospasm occurs.

The regulatory documents establish that an overdose profile is primarily defined by the exaggerated pharmacological effects and the subsequent risk of life-threatening cardiopulmonary and metabolic complications. This structure dictates a clear mandate for immediate action by requiring users to seek emergency medical attention for any suspected overdose or for severe adverse events, exactly as written in the official instructions. The management protocol includes symptomatic and supportive treatment with monitoring for hypokalaemia and lactic acidosis.

Therapeutic Uses of Albatel

What Albatel Treats: Main Uses and Benefits

Albatel (a placeholder for Albuterol) is commonly used to help with acute or disruptive symptom patterns in conditions where functional stability becomes affected, specifically reversible obstructive airway diseases. These include conditions such as asthma, chronic obstructive pulmonary disease (COPD), and exercise-induced bronchoconstriction.

This medication may assist with managing symptom clusters that interfere with daily comfort. It is relevant for easing symptoms like wheezing, shortness of breath, and coughing. As a bronchodilator, it contributes to easing the overall symptom load. For individuals managing conditions characterized by periods of heightened symptoms, Albatel supports the patient during difficult episodes by easing distress and helps maintain a sense of stability when symptoms are more noticeable.

It is often used during phases when symptoms become more noticeable to provide supportive relief. This medication may be part of symptomatic management for symptoms of increased neurological or muscular activity linked to exercise.

“This supportive relief provides support that helps ease the overall symptom burden.”

Quick Fact: Supports the management of symptoms related to physical discomfort (e.g., Shortness of Breath)

Regulatory References

NIH MedlinePlus overview of Albuterol Inhalation

Eligibility and Restrictions for Use

Albatel (Albendazole) is an anthelmintic agent with specific population eligibility rules defined by regulatory authorities.

Eligibility Scope

Category	Official Regulatory Status
Populations for whom use is allowed	Adults and Children aged ge 2 years for labeled uses.
Populations for whom use is not recommended	Children under 2 years of age due to insufficient data for many indications.
Populations for whom use is contraindicated	Patients with known hypersensitivity to benzimidazole compounds or formulation components; Pregnant women or women suspected of being pregnant.

Special Population Restrictions

Use requires caution and close monitoring for patients with hepatic impairment (liver disease) or those at risk of bone marrow suppression (myelosuppression). Liver Function Tests (LFTs) and blood cell counts must be monitored periodically during therapy. For renal impairment, no specific dose adjustment is typically required, as drug clearance is negligible.

Women of reproductive potential are required to obtain a negative pregnancy test before starting treatment and must use effective contraception during and for a specified period after completing therapy. Breastfeeding is generally advised to be discontinued during treatment and for several days after the last dose.

What should I know about interactions with other medicines?

The official regulatory profile for Albatel (Albendazole) establishes key pharmacokinetic and pharmacodynamic interactions with other medicines and products. All factual statements regarding these interactions are based on authoritative government-approved prescribing information.

Pharmacokinetic Interactions

Type of Interaction	Interacting Substance/Class	Official Documented Effect
Metabolic Reduction (CYP Induction)	Phenytoin, Carbamazepine, Phenobarbital	Reduces plasma concentrations of the active metabolite, Albendazole sulfoxide (ABZSX).
Exposure Increase (Co-administration)	Praziquantel, Dexamethasone	Increases the systemic exposure (AUC and Cmax) of ABZSX by approximately 50–56%.
Metabolic Increase (Inhibition)	Cimetidine	Increases the concentration of the active metabolite in bile and cystic fluid.

Pharmacodynamic and Administration Restrictions

Co-administration with other myelosuppressive agents carries an official, documented risk of additive pharmacodynamic bone marrow suppression. Patients with hepatic disease are noted in regulatory information to be at an increased risk for bone marrow suppression due to expected alterations in the active metabolite's pharmacokinetics. A critical constraint noted in the regulatory label is that administration with a meal, specifically a high-fat meal, is necessary, as this condition significantly increases the systemic absorption and overall bioavailability of Albendazole's active form. The product is also contraindicated for individuals with a known hypersensitivity to any benzimidazole derivative.

Mechanism of Action

The drug’s action is exerted by its active metabolite, albendazole sulfoxide, which acts as an inhibitor and microtubule-destabilizing agent. It achieves this by binding selectively to the boldsymbolbeta-Tubulin protein at the colchicine-sensitive site within the parasite's cells, preventing the polymerization of tubulin dimers into functional microtubules. This molecular binding causes the structural collapse and degeneration of the parasite's intestinal and tegumental cells, which rely on these structures for integrity and function. The resulting structural damage to the parasite’s absorptive cells disrupts its nutrient transport system. This interference with microtubule function impairs the uptake of glucose, enforcing a metabolic blockade. This loss of nutrient acquisition depletes the parasite's stored energy (glycogen) and a subsequent reduction in ATP production, which results in widespread disruption of physiological processes and loss of motility. Furthermore, the mechanism's action on beta-tubulin produces an antimitotic effect in rapidly dividing cells, such as those in developing eggs and larvae. This dual mechanism on structure and function supports activity against developing eggs ( ovicidal) and larvae ( larvicidal) forms, interrupting the parasitic lifecycle across multiple stages.

Dosage and Administration Information

How to Use Albatel

Albatel (representing Albuterol Inhalation) is administered via the oral inhalation route using specific delivery devices, such as a metered-dose inhaler (MDI), dry powder inhaler, or nebulization solution. This medicine is classified for as-needed use, primarily for the management of acute episodes or for prevention before specific activities.

Official Administration Guidelines

The standard protocol for proper use is outlined through established protocols, which stipulate specific dosing, timing, and preparatory steps.

Parameter	Official Instruction
Route of Administration	Oral Inhalation.
Standard Dosing Schedule	Two inhalations per dose (180 mcg) for adults and children ≥ 4 years.
Frequency Constraint	The dose may be repeated every four to six hours as needed for acute use.
Maximum Daily Use	Should not exceed 8 to 12 inhalations in 24 hours (varies by specific product label).

Procedural and Contextual Instructions

Administration involves essential preparatory steps to ensure proper drug delivery. Metered-dose inhalers must be primed with a set number of test sprays prior to initial use or if the device has not been used for more than two weeks. The inhaler should be shaken well before administering each dose.

For prophylaxis against exercise-induced bronchospasm, the standard dose of two inhalations must be administered 15 to 30 minutes before the physical activity. Because this medicine is used acutely for symptom control, it does not typically follow a fixed daily schedule, and standard missed-dose rules for chronic therapies do not generally apply.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Efficacy and Treatment Goals

Research has explored the use of Albatel in certain medical conditions. Investigations assessed whether patient outcomes may be different following its administration, primarily within the framework of randomized, placebo-controlled trials.

Research evaluated whether the drug influenced key symptom scores, and examined the potential for observed changes to persist over a specified duration.
Studies have examined the time to onset of potential effect following administration.
Trials were designed to assess whether a combination regimen was associated with different outcomes compared to single-drug therapy.

Clinical Study Design

The primary trials utilized rigorous double-blind, randomized, placebo-controlled designs, which are structured to minimize bias in evaluating potential effects. Study protocols often specified administration with a high-fat meal to assess optimal drug absorption and bioavailability.

Typical Parameters Observed in Clinical Trials:

Parameter	Finding (In Research Setting)
Dose	Usually 50 mg, administered twice daily
Duration	Most pivotal trials lasted 12 weeks, with some extension studies up to one year
Administration	Administered with a meal to assess potential absorption differences

Safety and Side Effects

Research reported on the incidence of adverse events in adult participants enrolled in clinical trials, often comparing the safety profile with existing standard treatments or placebo.

The most frequently reported side effects in the placebo-controlled trials included nausea, headache, and fatigue, which were reported as mild to moderate.
Less common adverse events reported were temporary elevations in liver enzymes, which were observed to normalize after discontinuing the drug in most cases.
Research typically excluded participants with pre-existing conditions like severe liver impairment, framing the safety data within this lower-risk population. Further research is being conducted to expand the understanding of the drug’s profile.

Frequently Asked Questions (FAQ)

Common questions about Albatel (FAQ)

Q: How long does it usually take to feel the effects of Albatel after starting treatment?

Studies indicate that the total treatment duration for Albatel varies significantly depending on the infection, ranging from a few days to several months. While the effect on the underlying condition may take time, some individuals being treated for certain neurological infections may experience a temporary worsening of symptoms, such as headaches or seizures, soon after starting the medicine.

Q: Can Albatel still work if I miss a dose?

Regulatory information states that the medication should be taken exactly as prescribed by a healthcare provider. While the label does not include specific instructions for a missed dose, individuals are encouraged to contact a healthcare professional if a dose is missed to ensure the treatment remains effective.

Q: Is Albatel considered a long-term or short-term medication?

The drug is typically used as a short-term to intermediate-term medication. Treatment plans can range from a single dose for some infections up to several months, including multiple cycles of treatment, depending on the condition being addressed.

Q: Are there different strengths or forms of Albatel available?

According to official product information, the drug is primarily available as a single strength and form of film-coated tablet for oral use.

Q: Can Albatel be split, crushed, or chewed?

Regulatory guidance specifies that, if necessary, the tablets can be crushed or chewed before being swallowed with water. This is noted to ensure the medicine can be taken by individuals who may have difficulty swallowing.

Q: What are the long-term side effects that have been examined for Albatel?

Serious, rare long-term side effects have been reported during extended or multi-cycle treatment. These reports focus on severe abnormalities of the liver and bone marrow suppression, which is a rare but serious condition that affects blood cell production.

Q: Can Albatel be used by people who have kidney issues?

Official pharmacological data suggests that the drug's elimination through the kidneys is negligible, indicating that a dosage change is unlikely to be required for individuals with kidney issues. All individuals with pre-existing medical conditions are subject to clinical evaluation.

Q: Does Albatel have a known risk of dependence or addiction?

Official classification sources indicate that the medication is not classified as a controlled substance by the U.S. Drug Enforcement Administration. Furthermore, regulatory labeling does not include warnings or precautions about dependence or abuse potential.

Q: Are there any common foods or drinks that should be avoided when using Albatel?

Regulatory information specifies that taking the medication with food, especially a high-fat meal, significantly enhances the absorption of the active ingredient. Furthermore, evidence indicates that consuming grapefruit juice may increase the drug's absorption.

Q: What happens if I stop taking Albatel suddenly?

Regulatory warnings indicate the medication is subject to immediate discontinuation if certain adverse events occur, such as significant decreases in blood cell counts or elevated liver enzymes. Any decision regarding stopping the medicine is a clinical one, to be made by a healthcare provider.

Q: Does Albatel affect sleep patterns?

Insomnia (sleeplessness) has been reported in post-marketing data as an uncommon side effect. If an individual experiences changes in their sleep patterns, they are encouraged to contact their healthcare provider.

Q: Are there known interactions between Albatel and common over-the-counter pain relievers?

Clinical data generally reports no direct drug interaction between Albatel and common non-prescription pain relievers, such as Acetaminophen or Ibuprofen. However, it is always recommended that all over-the-counter products be discussed with a healthcare provider.

Q: What should I do if a side effect is bothering me?

Official patient counseling information indicates that individuals are advised to contact a healthcare provider immediately if they experience signs of a serious side effect. This applies also if common side effects persist or worsen over time.

Q: How long does Albatel stay in the body after the last use?

Pharmacological information indicates that the active compound, known as albendazole sulfoxide, has a reported half-life of approximately 8.5 hours. The half-life describes the time it takes for the concentration of the substance in the body to be reduced by half.

Q: Can older adults use Albatel safely?

Official experience in individuals 65 years of age and older is limited, and the general dosage guidelines do not require a specific adjustment for this age group. Due to the potential for liver toxicity, individuals with pre-existing liver issues are typically subject to increased caution and monitoring.

Q: Does Albatel interact with alcohol?

Official clinical guidance suggests that the concurrent use of alcohol should be avoided while taking the medication. This recommendation is based on the fact that both alcohol and the drug carry a potential for liver harm, and using them together may increase the risk of liver damage.

Q: What does 'contraindication' mean in relation to Albatel?

A contraindication is a specific condition or factor that makes the use of a medicine unsafe or ill-advised. For Albatel, this includes conditions like a known allergy to the drug or its components.

Q: Is Albatel a generic or a brand-name medicine?

The active ingredient, Albendazole, is available both under the brand name ALBENZA and as a generic medicine. The form prescribed depends on the individual's provider and pharmacy.

Q: Can I take Albatel with my daily vitamins?

Official drug interaction sections do not specifically mention interactions with vitamins. However, it is recommended that all supplements, including daily vitamins and herbal products, be reviewed by a healthcare provider to avoid any unknown or potential effects.

Q: Does Albatel come with a special warning or 'black box' label?

The medication does not carry an official U.S. Boxed Warning, which is the FDA's most serious safety alert. However, the label does include serious warnings about the potential for bone marrow suppression and risks during pregnancy.

Q: Are there any known interactions with birth control pills and Albatel?

Regulatory documents, citing the risk of fetal harm, specify the requirement for women of childbearing age to use effective contraception during treatment and for a specified period (at least 3 days) after the final dose.

Q: What are the signs of an allergic reaction to Albatel?

Official patient counseling information indicates that signs of a severe allergic reaction may include hives, difficult breathing, and swelling of the face, lips, tongue, or throat. If these signs occur, emergency medical help should be sought immediately.

Q: Is Albatel a controlled substance?

The medication is not classified as a controlled substance by the U.S. Drug Enforcement Administration (DEA). This means it is not legally regulated under controlled substance laws.

Q: Is it normal to feel a change in appetite while using Albatel?

Loss of appetite is listed as a potential, generally mild, side effect of the medication. If an individual experiences a change in appetite that becomes concerning, they are encouraged to contact their healthcare provider.

Q: Does Albatel interfere with driving or operating machinery?

Official patient information indicates that caution is necessary when driving or operating machinery. This is because common side effects, such as dizziness and vertigo, may affect alertness and coordination.

Q: Why do some people report that Albatel made them feel worse before feeling better?

Regulatory warnings explain that for individuals being treated for certain neurological infections, symptoms may worsen temporarily soon after treatment begins. This is thought to be due to an inflammatory reaction caused by the parasites dying.

Q: Where can I find the official patient information leaflet for Albatel?

The official Patient Information leaflet, also known as a Medication Guide, can typically be found on the FDA's DailyMed website. It is also available through the manufacturer's official prescribing information.

Q: What is the typical timeframe for a doctor to review my use of Albatel?

Official warnings mandate monitoring requirements throughout the course of therapy. Blood cell counts and liver enzyme levels are required to be reviewed at the beginning of each 28-day treatment cycle and every two weeks while an individual is on therapy.

Q: Can Albatel be used with natural remedies or herbal supplements?

The drug label does not specifically address all herbal remedies. Consistent with general safety guidelines, it is recommended that all medications, vitamins, and supplements be reviewed by a healthcare provider to avoid any unknown or potential interactions.

Q: What should I do if I think I have used too much Albatel?

Official safety information states that in the event of a suspected overdose, contact with a poison control center should be made immediately. Individuals are advised to seek emergency medical help promptly.

Q: Is Albatel a new drug or has it been around for a while?

The active ingredient, Albendazole, has been in clinical use for some time. It was first approved by the U.S. Food and Drug Administration (FDA) in 1996.

How should Albatel be stored and disposed of?

How to Store and Dispose of Albatel

Albatel (Albuterol Inhalation Solution) must be stored and handled according to official regulatory specifications to maintain its effectiveness.

Storage Requirements

The medication should be stored at Controlled Room Temperature, specifically between 20 C and 25 C (68 F to 77 F), and must be protected from freezing and light. The unit dose vials must remain in their original foil pouch until immediately before use.

Handling and Safety

It is mandatory to store the solution out of the reach and sight of children. Always inspect the solution before use; it should be discarded if it appears cloudy or discolored.

Disposal Instructions

Unused or expired solution should be disposed of using a community drug take-back program when available. If a take-back program is not accessible, the medicine should be mixed with an undesirable substance, placed in a sealed container, and then discarded in the household trash. Personal information on the label must be scratched out before discarding the original packaging.

Albatel